🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in Canada / NCT07002853
Recruiting Not applicable

Nature-based Intervention for Chronic Pain in Older People

NCT07002853 · tracked via the Priya Life Science Canada tracker
Phase
Not applicable
Started
2025-05-22
Last updated
2025-06-04

Condition(s) studied

Chronic DiseaseChronic Pain (Back / Neck)Older Adults (65 Years and Older)

Investigational drug(s) / intervention(s)

Nature-based Intervention

Nature-based Intervention: Combination of activities in nature such as walking, exercises (strengthening, mobility, balance), mindfulness, guided meditation, forest bathing or Shinrin-Yoku, interpretation of nature, gardening and pain education.

Study summary

The goal of this clinical trial is to learn if a nature-based intervention program has positive effects on the physical and psychosocial health in a group of older participants with chronic non-specific lower back pain. The main questions it aims to answer are:

Will the program improve:

* The physical outcomes such as mobility, strength and balance?
* The psychosocial health outcomes?

Participants will:

* Be assessed before and after the program;
* Participate in one session per week of the intervention.

Eligibility

Sex
ALL
Min age
65 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * Aged 65 years + * Having low back pain for 3 months or more * Being able to walk independently * Mental state \>25/30 in the MMSE questionnaire * Frailty score \<3/5 (Fried criterias) Exclusion Criteria: * Presenting other severe musculoskeletal, cardiovascular, or neurological conditions, or systemic diseases (e.g., cancer).

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Université du Québec à Chicoutimi Saguenay Quebec Recruiting

More Université du Québec à Chicoutimi trials in Canada

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07002853 on ClinicalTrials.gov ↗ ← All trials in Canada